Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
MPM ASSET MANAGEMENT LLC (CIK 1263048) reported $44.5M across 4 reported positions in its SEC 13F filing for 2025-09-30. Largest positions: TRDA ($25.4M, 57.09%), DYN ($8.6M, 19.40%), HOWL ($8.5M, 19.08%), RPTX ($2.0M, 4.43%), ADAP ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TRDA | Entrada Therapeutics, Inc. | $25.4M | 57.09% | 4.4M | Hold |
| 2 | DYN | Dyne Therapeutics, Inc. | $8.6M | 19.40% | 682,376 | Hold |
| 3 | HOWL | Werewolf Therapeutics, Inc. | $8.5M | 19.08% | 4.3M | Hold |
| 4 | RPTX | Repare Therapeutics, Inc. | $2.0M | 4.43% | 1.1M | Hold |
| 5 | ADAP | Adaptimmune Therapeutics plc | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-09-30